Quantitative assessment of cell viability and apoptosis in cultured epidermal autografts: application to burn therapy.
Cultured epidermal autografts (CEA) have been used in the treatment of burns for almost two decades but the clinical results are still inconsistent. In a group of 37 patients with extensive burn wounds admitted to the University Hospital of Lausanne, CEA take ranged between 10 and 100% with a mean of 65%. To investigate CEA efficacy in burns, twelve CEA preparations were tested for their biological properties with particular emphasis on the balance between cell viability and apoptosis. Apoptosis was evaluated by in situ end-labeling (TUNEL), detection of DNA fragments in CEA extracts and analysis of caspase-3 activity. All CEA samples displayed a high cell viability (> 90%) and a low apoptosis rate (< 6%). However, several biological parameters including the activity of transglutaminase showed wide interindividual variability suggesting that CEA therapeutic efficacy could be partly determined by intrinsic biological factors.
Vernez
M
M
Department of Dermatology, University Hospital (CHUV), Lausanne, Switzerland.
Raffoul
W
W
Gailloud-Matthieu
M C
MC
Egloff
D
D
Senechaud
I
I
Panizzon
R G
RG
Benathan
M
M
D000293:Adolescent; D000328:Adult; D017209:Apoptosis; D002056:Burns / Q000601:surgery*; D002470:Cell Survival; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D053938:DNA Fragmentation; D005260:Female; D006801:Humans; D020287:In Situ Nick-End Labeling; D007223:Infant; D015603:Keratinocytes / Q000637:transplantation; D008297:Male; D008875:Middle Aged; D016038:Skin Transplantation; D011503:Transglutaminases / Q000378:metabolism; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014945:Wound Healing
D011503:Transglutaminases